AZD8630, AZD8630, AZD8630 Placebo, AZD8630
D6830C00003
Phase 2 small_molecule active
Quick answer
AZD8630, AZD8630, AZD8630 Placebo, AZD8630 for Asthma in adults who remain uncontrolled despite medium to high dose ICS plus LABA, and who are at risk of exacerbations. is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Asthma in adults who remain uncontrolled despite medium to high dose ICS plus LABA, and who are at risk of exacerbations.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active